RVL Pharmaceuticals plc - ROE
RVLP
Price:
$0.0282
Market Cap:
$3.14M
RVL Pharmaceuticals plc operates as a specialized pharmaceutical firm, concentrating on the creation and commercialization of medicinal products. These offerings target patient populations with unmet needs within the fields of ocular health and medical aesthetics across the United States, Argentina, and Hungary. Among its key commercialized products is Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution specifically developed for adults experiencing acquired blepharoptosis, or drooping eyelids. The company, whose corporate headquarters are located in Bridgewater, New Jersey, underwent a name change in January 2022, transitioning from its former identity as Osmotica Pharmace...[Read more]
Industry
Biotechnology
IPO Date
2018-10-19
Stock Exchange
NASDAQ
Ticker
RVLP
PE Ratio
[-0.04]
ROE
[-80.88%]
Current Ratio
[2.89]
Dividend Yield
[0%]
Enterprise Value
[16.09M]
Dividend History
The ROE as of June 2026 (TTM) for RVL Pharmaceuticals plc (RVLP) is -80.88%
According to RVL Pharmaceuticals plc’s latest financial reports and current stock price. The company's current ROE is -80.88%. This represents a change of 39.28% compared to the average of -58.07% of the last 4 quarters.
RVL Pharmaceuticals plc (RVLP) Historical ROE (quarterly & annually)
How has RVLP ROE performed in the past?
The mean historical ROE of RVL Pharmaceuticals plc over the last ten years is -84.07%. The current -80.88% ROE has changed -3.79% with respect to the historical average. Over the past ten years (40 quarters), RVLP's ROE was at its highest in in the June 2018 quarter at 1.40%. The ROE was at its lowest in in the June 2023 quarter at -146.32%.
Average
-84.07%
Median
-94.84%
Minimum
-236.17%
Maximum
-8.99%
RVL Pharmaceuticals plc (RVLP) ROE by Quarter and Year
Discovering the peaks and valleys of RVL Pharmaceuticals plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 726.50%
Maximum Annual ROE = -8.99%
Minimum Annual Increase = -59.84%
Minimum Annual ROE = -236.17%
| Year | ROE | Change |
|---|---|---|
| 2022 | -101.17% | -6.30% |
| 2021 | -107.97% | 13.84% |
| 2020 | -94.84% | -59.84% |
| 2019 | -236.17% | 726.50% |
| 2018 | -28.57% | 165.31% |
| 2017 | -10.77% | 19.80% |
RVL Pharmaceuticals plc (RVLP) Average ROE
How has RVLP ROE performed in the past?
The current ROE of RVL Pharmaceuticals plc (RVLP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-101.33%
5-year avg
-113.74%
10-year avg
-84.07%
RVL Pharmaceuticals plc (RVLP) ROE vs. Peers
How is RVLP’s ROE compared to its peers?
RVL Pharmaceuticals plc’s ROE is greater than Idera Pharmaceuticals, Inc. (-113.18%), greater than Affimed N.V. (-100.55%), less than Q32 Bio Inc. (230.68%), greater than Aravive, Inc. (-306.06%), greater than Atreca, Inc. (-83.28%), greater than Eiger BioPharmaceuticals, Inc. (-367.00%), greater than Unity Biotechnology, Inc. (-500.62%), greater than Onconetix, Inc. (-105.46%), less than Biophytis S.A. (92.02%), greater than Gritstone bio, Inc. (-124.41%),
| Company | ROE | Market cap |
|---|---|---|
| -113.18% | $0 | |
| -100.55% | $2.98M | |
| 230.68% | $152.04M | |
| -306.06% | $2.95M | |
| -83.28% | $3.57M | |
| -367.00% | $12.59M | |
| -500.62% | $3.44M | |
| -105.46% | $315.29K | |
| 92.02% | $2.61M | |
| -124.41% | $3.80M |
Build a custom stock screener for RVL Pharmaceuticals plc (RVLP) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RVL Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
RVL Pharmaceuticals plc (RVLP) and other stocks custom spreadsheet templates
The easiest way to analyze a company like RVL Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is RVL Pharmaceuticals plc's ROE?
How is the ROE calculated for RVL Pharmaceuticals plc (RVLP)?
What is the highest ROE for RVL Pharmaceuticals plc (RVLP)?
What is the 3-year average ROE for RVL Pharmaceuticals plc (RVLP)?
What is the 5-year average ROE for RVL Pharmaceuticals plc (RVLP)?
How does the current ROE for RVL Pharmaceuticals plc (RVLP) compare to its historical average?